Beta Drugs Limited (NSE:BETA)
India · Delayed Price · Currency is INR 2,073.30
+20.30 (0.99%)
Last updated: Oct 1, 2026, 3:29 PM IST
Beta Drugs Market Cap
Beta Drugs has a market cap or net worth of 21.02 billion as of October 1, 2026. Its market cap has increased by 14.41% in one year.
Market Cap
21.02B
Enterprise Value
21.25B
Revenue
4.10B
Ranking
n/a
PE Ratio
46.79
Stock Price
2,073.30
ChartMarket Cap Chart
Since October 25, 2017, Beta Drugs's market cap has increased from 915.98M to 21.02B, an increase of 2,194.46%. That is a compound annual growth rate of 41.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 21.02B | 34.40% |
| Dec 31, 2025 | 15.64B | -19.04% |
| Dec 31, 2024 | 19.31B | 36.67% |
| Dec 29, 2023 | 14.13B | 107.04% |
| Dec 30, 2022 | 6.83B | 10.89% |
| Dec 31, 2021 | 6.16B | 497.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orchid Pharma | 50.57B |
| RPG Life Sciences | 50.23B |
| Solara Active Pharma Sciences | 35.00B |
| Ind-Swift Laboratories | 34.36B |
| Sakar Healthcare | 23.92B |
| Indoco Remedies | 23.24B |
| Windlas Biotech | 22.34B |
| Anlon Healthcare | 17.47B |